throbber
Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 1 of 117 PageID#
`36619
`
`Exhibit 3
`Public Redacted Version
`
`

`

`
`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 2 of 117 PageID#
`
`36620
`
`
`
`INTENSITY
`
`
`
`
`
`
`
`
`
`
`
`INTENSITY, LLC
`intensity.com
`
`
`
`
`
`
`
`UNITED STATES DISTRICT COURT
`FOR THE EASTERN DISTRICT OF VIRGINIA
`ALEXANDRIA DIVISION
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case No. 1:20-cv-00393-LMB-WEF
`
`
`
`
`DECLARATION OF
`RYAN SULLIVAN, Ph.D.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`PHILIP MORRIS PRODUCTS S.A.,
`
`Plaintiff,
`
`
`
`R.J. REYNOLDS VAPOR COMPANY,
`
`Defendant.
`
`v.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`CONFIDENTIAL BUSINESS INFORMATION – SUBJECT TO PROTECTIVE ORDER
`
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 3 of 117 PageID#
`36621
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 4 of 117 PageID#
`36622
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 5 of 117 PageID#
`36623
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 6 of 117 PageID#
`36624
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 7 of 117 PageID#
`36625
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 8 of 117 PageID#
`36626
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 9 of 117 PageID#
`36627
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 10 of 117 PageID#
`36628
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 11 of 117 PageID#
`36629
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 12 of 117 PageID#
`36630
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 13 of 117 PageID#
`36631
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 14 of 117 PageID#
`36632
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 15 of 117 PageID#
`36633
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 16 of 117 PageID#
`36634
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 17 of 117 PageID#
`36635
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 18 of 117 PageID#
`36636
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 19 of 117 PageID#
`36637
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 20 of 117 PageID#
`36638
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 21 of 117 PageID#
`36639
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 22 of 117 PageID#
`36640
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 23 of 117 PageID#
`36641
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 24 of 117 PageID#
`36642
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 25 of 117 PageID#
`36643
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 26 of 117 PageID#
`36644
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 27 of 117 PageID#
`36645
`
`Attachment A-1
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 28 of 117 PageID#
`36646
`
`1111!®
`iiil INTENSITY
`
`Ryan Sullivan, Ph.D.
`President
`
`INTENSITY, LLC
`www.intensity.com
`
`September 2022
`
`Ryan Sullivan, Ph.D. is President of Intensity, LLC and provides expertise in economics, finance,
`and statistics. He applies his expertise to solve complex and challenging issues that
`organizations face in the competitive marketplace and the courtroom.
`■ Litigation & Disputes. Dr. Sullivan has wide-ranging experience with the economics of
`intellectual property and technology, technically demanding analyses of antitrust and
`competition, robust statistical modeling for labor and employment issues, and detailed
`quantitative analyses for securities and finance disputes.
`
`■ Business Analytics. Dr. Sullivan develops and implements state-of-the-art predictive models
`that provide reliable, evidence-based insights into business outcomes. These predictive
`models are implemented across a spectrum of business challenges, including price
`optimization, promotional programs, business strategy, forecasting, and investing.
`
`Dr. Sullivan is a recognized top U.S. economic expert by Intellectual Asset Management in each
`year from 2014 to 2021. Dr. Sullivan was rated at the top gold-band level reserved for those
`professionals highest among their peers in the field. According to IAM, "Ryan Sullivan uses
`sophisticated economic models to solve the trickiest damages conundrums."
`1AM further
`commented that the "outstanding academician is celebrated for his creative but rigorous, data
`driven approach and deep engagement with the questions at hand."
`
`Dr. Sullivan is often retained to provide expert testimony in high-stakes commercial litigation.
`He has provided expert testimony in more than a dozen cases that each had more than $1 billion
`in controversy. Dr. Sullivan has testified at trial in more than 25 cases and provided expert
`reports and deposition testimony in more than 100 cases. Dr. Sullivan's litigation-related work
`includes the following cases:
`
`■ Juno Therapeutics v. Kite Pharma. Dr. Sullivan worked on behalf of Juno Therapeutics and
`Sloan Kettering in patent litigation involving cancer immunotherapy. Juno, a subsidiary of
`Bristol-Myers Squibb, and Sloan Kettering claimed that Kite Pharma, a subsidiary of Gilead
`Sciences, infringed their patent. The technology at issue involved genetically engineering T­
`cells to fight cancer, which is known as CAR-T therapy. Economic issues included the
`contribution of the patented technology to Kite's allegedly infringing product, availability of
`potential non-infringing alternatives, stage of development of licensed technology,
`competitive relationship between Juno and Kite, financial harms and benefits from use of
`the patented technology by Kite, and market analysis of related license agreements.
`
`

`


`

`
`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 29 of 117 PageID#
`36647
`
` Lucent v. Microsoft. Dr. Sullivan worked on behalf of Microsoft in patent litigation involving
`video coding technology. Lucent Technologies and Multimedia Patent Trust claimed that
`the Microsoft Windows operating system and Xbox 360 infringed their patent. Dr. Sullivan
`evaluated the contribution of the patented technology to Microsoft’s products and the effects
`of licensing through patent pools. Economic issues included patent pools, cross licensing,
`FRAND rates, software cost structure, and reasonable royalties.
`
` Abbott Cardiovascular v. Edwards Lifesciences. Dr. Sullivan worked on behalf of Edwards
`Lifesciences in patent litigation involving devices used to treat mitral regurgitation, where
`the leaflets of the mitral valve do not close tightly and allow blood to backfill into the heart.
`Abbott claimed that Edwards’ PASCAL device violated several of its patents and was harming
`sales of its competing MitraClip product. Abbott sought injunctive relief and economic
`damages. Economic issues included an examination of products in the structural heart
`device marketplace, market definition, competition, pricing dynamics, existing license
`agreements, and product substitution patterns at the customer level.
`
` Ritz v. SanDisk. Dr. Sullivan worked on behalf of plaintiffs in antitrust litigation involving
`NAND flash memory and related patent licensing. Dr. Sullivan’s evaluation of price injury
`included analysis of licensing revenue, apportionment of licensing revenue to disputed
`patents, and implementation of an econometric model relating product pricing to competitor
`costs and other factors. Economic issues included market definition, market power, class
`definition, apportionment, and pass-through of costs.
`
` T-Mobile v. Huawei. Dr. Sullivan worked on behalf of T-Mobile in trade secret litigation
`involving Huawei’s misappropriation of T-Mobile’s robot testing system for mobile devices.
`Dr. Sullivan evaluated T-Mobile’s actual losses and Huawei’s unjust enrichment resulting
`from Huawei’s misappropriation of trade secrets and breach of contract. Economic issues
`included the technology’s contribution to profits, supply agreements, product sales, and
`product costs.
`
`Dr. Sullivan served as an invited member of the Economics Leadership Council at the University
`of California, San Diego. In this role, he provided guidance to the Department of Economics
`faculty on the application of economic science in private industry.
`
`Dr. Sullivan served as the Treasurer and an officer on the Board of Trustees for San Diego Zoo
`Global, now known as the San Diego Zoo Wildlife Alliance, which is an international, nonprofit
`conservation organization with two front doors: the San Diego Zoo and the San Diego Zoo Safari
`Park.
`
`Dr. Sullivan earned his B.A., M.A., and Ph.D. in economics from the University of California, San
`Diego. While at UC San Diego, Dr. Sullivan used advanced statistical methods to evaluate the
`predictive ability of econometric models. He has published economic research in top-tier, peer-
`reviewed academic journals—including the Journal of Finance, the Journal of Econometrics, and
`the International Journal of Forecasting—as well as articles on the economics of intellectual
`assets.
`
`
`CV of Ryan Sullivan, Ph.D.
`
`
`
`
`Page 2 of 18
`
`

`


`

`
`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 30 of 117 PageID#
`36648
`
`Dr. Sullivan has provided professional economic services since 1992. He established Quant
`Economics, Inc. in 2006 and Intensity in 2014.
`
`Education
`Ph.D., Economics, University of California, San Diego
`
`M.A., Economics, University of California, San Diego
`
`B.A., Economics, University of California, San Diego
`
`Employment
`Intensity, LLC. President, 2014 to present.
`
`Quant Economics, Inc. President, 2006 to 2014.
`
`Bates White, LLC. Manager, 2001 to 2003. Principal, 2003 to 2006.
`
`Econ One Research, Inc. Economist, 2000 to 2001.
`
`Economic Analysis, LLC. Economist, 1998 to 2000.
`
`INDETEC International, Inc. Economic Analyst, 1992 to 1998.
`
`Professional Experience
`
` Litigation & Disputes
` Dr. Sullivan has wide-ranging experience with the economics of intellectual property and
`technology across life sciences, consumer electronics, and other industries. In one example,
`he calculated the profits lost by a branded drug company as a result of an “at-risk” launch
`of generic versions of a blockbuster drug by generic drug suppliers, including reconstruction
`of the market but for the alleged infringement and detailed analysis of price effects. In
`another example, he calculated reasonable royalties in litigation involving video coding
`technology used in personal computers and gaming devices, including investigation of
`standard-essential patents, reasonable and non-discriminatory licensing practices, and the
`impact of patent licensing pools.
`
` Dr. Sullivan develops technically demanding analyses of antitrust and competition in the
`context of merger evaluation, antitrust claims, and related issues, such as alleged unfair
`competition and breach of contract. In one example, he examined allegations of tying,
`exclusive dealing, and other anticompetitive conduct in the aerospace equipment industry.
`His market power inquiry included defining the relevant market and directly determining
`competitive effects of the alleged conduct. In another example, Dr. Sullivan developed
`sophisticated statistical models of product sales to estimate economic damages. In addition
`
`
`CV of Ryan Sullivan, Ph.D.
`
`
`
`
`Page 3 of 18
`
`

`


`

`
`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 31 of 117 PageID#
`36649
`
`to measuring the effect of the alleged conduct, his models included a scientific test to assess
`the fact of damages.
`
` Dr. Sullivan applies robust statistical analyses to evaluate labor and employment issues. In
`one example, he evaluated a statistical sampling methodology for estimating the amount of
`time spent by managers performing non-exempt duties, which informed class certification.
`In another example, Dr. Sullivan evaluated the economic impact of an employee raid
`between two large insurance companies, using an econometric model that accurately
`separated the effects of the alleged conduct from unrelated factors, including the 2008
`financial crisis.
`
` Dr. Sullivan implements detailed quantitative analyses for securities and finance disputes.
`In one example, he developed a probabilistic model of distressed equity and drivers of value,
`and advised on reliable trading strategies. In another example, he conducted detailed
`statistical analysis of stock options to test whether the pattern of observed option grants
`utilized unfair hindsight or sound foresight. In a third example, Dr. Sullivan implemented
`sophisticated event-study analyses and stock trading models to calculate economic damages
`to investors resulting from alleged accounting misstatements and other fraudulent claims.
`
` Business Analytics
` Dr. Sullivan develops and implements state-of-the-art predictive models that provide
`reliable, evidence-based insights into business outcomes. These predictive models are
`implemented across a spectrum of business challenges, including price optimization,
`promotional programs, business strategy, and forecasting.
`
` Dr. Sullivan designs and develops price optimization programs that systematically improve
`business performance. In one example, he designed a price improvement program for a
`high-traffic online retailer that sells a diverse set of products that have widely varying
`consumer price sensitivity. His approach combined scientific testing that measures
`consumer response with adaptive pricing models that continuously update prices as market
`conditions change. In another example, Dr. Sullivan developed high-frequency price
`updating strategies that optimize a specialized statistic of business performance that
`includes revenue per order, profit per order, conversion rate, and repurchase rate.
`
` Dr. Sullivan designs and implements scientifically valid analyses that directly guide
`promotional activity and demonstrably improve customer engagement. For example, he
`performed analysis for pharmaceutical companies to determine which physicians should be
`visited, when they should be detailed, and how many samples should be provided at each
`visit. In another example, Dr. Sullivan designed a promotional testing and optimization
`program that combined individual customer attributes and dynamic market factors to
`deliver unique communications to each customer, including variation among types of
`discounts, featured products, and messaging.
`
` Dr. Sullivan applies real-world economic expertise to solve challenging problems facing
`sports franchises, player associations, and entertainment companies. In one example, he
`performed extensive economic analysis of digital video recorder technology, its effect on
`
`
`CV of Ryan Sullivan, Ph.D.
`
`
`
`
`Page 4 of 18
`
`

`


`

`
`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 32 of 117 PageID#
`36650
`
`consumer viewing behavior, and corresponding impacts on the value of live sports content.
`In another example, Dr. Sullivan
`investigated compensation mechanisms, player
`constraints, and strategic bargaining in the context of professional sports leagues, including
`a combination of economic theory and detailed data analysis to identify means of
`improvement for both players and teams.
`
` Dr. Sullivan employs predictive analytics that target a collection of performance metrics for
`determining reliable investments, including equity selection, trade timing, position size,
`duration of entry, and duration of exit. Select performance metrics include company
`revenue, company earnings, trade volume, and returns. Dr. Sullivan also incorporates
`state-of-the-art business cycle forecasts that quantify high-dimensional, time-varying
`relationships, as well as risk management techniques that limit downside movements.
`
` Dr. Sullivan implements methods that avoid data snooping, spurious correlations, look-
`ahead bias, and overfitting. Early in his career, Dr. Sullivan pioneered the application of
`advanced statistical methods that quantify data-snooping biases, which occur when a given
`set of data is used more than once for purposes of inference or model selection. When such
`data reuse occurs, there is a possibility that any seemingly positive model performance may
`simply be due to chance rather than any merits of the model. Through more than two
`decades of hands-on work in predictive modeling, Dr. Sullivan developed methodologies that
`effectively combine statistical techniques to reduce data-snooping biases and deliver reliable
`results.
`
`Publications and Papers
`Sullivan, Ryan, DeForest McDuff, and Justin Skinner: “Downgrade to ‘Neutral’: A Diminishing
`Role of the Georgia-Pacific Factors in Reasonable Royalty Analyses,” (2015) les Nouvelles 50(3),
`134-137.
`
`Sullivan, Ryan and John Scherling: “Reincarnation of Reasonable Royalty Damages,” (2015)
`Intellectual Property Magazine, May 2015, 58-60.
`
`Sullivan, Ryan and DeForest McDuff: “AstraZeneca and Damages In ‘At-Risk’ Generic Drug
`Launches” (2015) Law360, April 28, 2015.
`
`Schayes, Danny, Mickey Ferri, and Ryan Sullivan: “One and Done: A Data-Driven Analysis”
`(2014) Intensity Corporation.
`
`Schayes, Danny and Ryan Sullivan: “How Much are the Atlanta Hawks Worth?” (2014) Sheridan
`Hoops, September 11, 2014.
`
`Sullivan, Ryan and John Scherling: “Rational Reasonable Royalty Damages: A Return to the
`Roots,” (2011) Landslide 4(2), 55–58.
`
`Sullivan, Ryan: “A Holistic Approach to Patent Damages Analysis,” (2006) in Daniel Slottje, ed.,
`Economic Damages in Intellectual Property: A Hands-On Guide to Litigation, John Wiley & Sons.
`
`Sullivan, Ryan, Allan Timmermann, and Halbert White: “Forecast Evaluation with Shared Data
`Sets,” (2003) International Journal of Forecasting 19(2), 217-227.
`
`
`CV of Ryan Sullivan, Ph.D.
`
`
`
`
`Page 5 of 18
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 33 of 117 PageID#
`36651
`
`Sullivan, Ryan, Allan Timmermann, and Halbert White: “Dangers of Data-Mining: The Case of
`Calendar Effects in Stock Returns,” (2001) Journal of Econometrics 105(1), 249-286.
`
`Sullivan, Ryan, Allan Timmermann, and Halbert White: “Data-Snooping, Technical Trading Rule
`Performance, and the Bootstrap,” (1999) Journal of Finance 54(5), 1647-1691.
`
`Sullivan, Ryan, and Halbert White: “Finite Sample Properties of the Bootstrap Reality Check for
`Data-Snooping: A Monte Carlo Assessment,” (1999) UCSD manuscript.
`
`Sullivan, Ryan: “Instability and Prediction Error in Model Selection,” (1996) UCSD manuscript.
`
`Sullivan, Ryan: “A Neural Network Forecast of the S&P 500,” (1995) UCSD manuscript.
`
`Speaking Engagements
`“Applied Economics and Business Analytics,” Rady School of Management, University of
`California, San Diego, March 2020.
`
`“Applied Economics and Business Analytics,” ECONference, University of California, San Diego,
`April 2019.
`
`“Feedback Loop of Licensing and Royalties,” San Diego Intellectual Property Law Association,
`October 2018.
`
` “A Brave New World of Patent Damages,” San Diego Intellectual Property Law Association, April
`2016.
`
`Keynote address, “Perfecting the Science of Professional Success,” 7th Annual Winter Business
`Leadership Conference, Rady School of Management, University of California, San Diego,
`January 2015.
`
` “Application of Economic Science in Private Industry,” MicroMBA, Rady School of Management,
`University of California, San Diego, June 2014.
`
`“Asset Valuation for Patent Monetization: A review of valuation methods and transaction
`structures,” Best Practices in Patent Monetization, San Francisco, California, March 2014.
`
`Keynote address, “Perfecting the Science of Personal Achievement,” Financial Horizons
`Conference, Rady School of Management, University of California, San Diego, March 2013.
`
`“Reasonable Royalty Damages: A Return to the Roots,” American Bar Association, February
`2012.
`
`“Patent Damages: Economic Perspectives on Lucent, ResQNet, and Uniloc,” San Diego
`Intellectual Property Law Association, February 2011.
`
`“Economics in Patent Litigation,” University of San Diego, School of Law, February 2010.
`
`“The Evolution of Patent Damages,” Orange County Patent Law Association, November 2007.
`
`“Economics of Intellectual Property,” San Diego County Bar Association, Carmel Valley / UTC
`Section, March 2007.
`
`CV of Ryan Sullivan, Ph.D.
`
`Page 6 of 18
`
`

`


`

`
`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 34 of 117 PageID#
`36652
`
`Financial Horizons Conference, Undergraduate Investment Society, University of California, San
`Diego, March 2007.
`
`“Allocating Risk in Intellectual Property Licensing Agreements,” CommNexus San Diego,
`November 2006.
`
`“The Master Class on Licensing Agreements for the Financial Services Industry” and “Asserting
`Rights to Your Financial Services Innovation through Patent Litigation,” Optimizing Patents and
`IP in Financial Products & Services, New York, New York, June 2006.
`
`Keynote address, “Economics in Intellectual Property,” California Bar Association, 30th Annual
`Intellectual Property Institute, Napa Valley, California, November 2005.
`
`“Initial Analysis and Planning: Choosing the Expert and Getting Started,” Expert testimony in
`litigation: Capitalizing on expertise for success, Reston, Virginia, December 2004.
`
`“Initial Analysis and Planning: Choosing the Expert and Getting Started,” Effective financial
`expert testimony: Significant strategies and tactics, San Francisco, California, November 2004.
`
`“Applying Daubert Principles to the Use of Computer Simulation to Develop an Estimate of the
`‘But For’ World for Damages Calculations,” Calculating and proving patent damages: Beyond the
`usual courses of action for pursuit and defense, Seattle, Washington, November 2004.
`
`“Applying Daubert Principles to the Use of Computer Simulation to Develop an Estimate of the
`‘But For’ World for Damages Calculations,” Calculating and proving patent damages: Beyond the
`usual courses of action for pursuit and defense, Atlanta, Georgia, October 2004.
`
`“Taking a Holistic Approach to Patent Damages Analysis,” Calculating and proving patent
`damages: Recent developments and new tools for success, San Francisco, California, July 2004.
`
`Professional Services and Associations
`Referee, American Economic Review
`
`Referee, Journal of Business
`
`Referee, Journal of Econometrics
`
`Referee, Journal of Financial Econometrics
`
`Referee, Journal of Financial Research
`
`Referee, Journal of Forecasting
`
`Referee, Quantitative Finance
`
`Member, American Economic Association
`
`Member, American Finance Association
`
`Member, Econometric Society
`
`Member, Economics Leadership Council, University of California, San Diego
`
`
`CV of Ryan Sullivan, Ph.D.
`
`
`
`
`Page 7 of 18
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 35 of 117 PageID#
`36653
`
`Member, Licensing Executives Society
`
`Associate Member, American Bar Association, Intellectual Property and Antitrust Sections
`
`Treasurer, Board of Trustees, San Diego Zoo Global
`
`Expert Testimony
`
`1.
`
`2.
`
`3.
`
`4.
`
`5.
`
`6.
`
`7.
`
`8.
`
`9.
`
`10.
`
`11.
`
`12.
`
`District of Columbia v. NRA Foundation, Inc. and National Rifle Association of America.
`Superior Court for the District of Columbia, Case No. 2020 CA 003454 B. Expert report.
`
`PACT XPP Schweiz AG v. Intel Corporation. United States District Court, District of
`Delaware, Case No. 1:19-cv-01006. Expert report and deposition.
`
`Natera, Inc. v. ArcherDX, Inc., ArcherDX, LLC, and Invitae Corp. United States District
`Court, District of Delaware, Case No. 1:20-cv-00125. Expert report and deposition.
`
`Eolas Technologies Incorporated v. Google LLC. United States District Court, Northern
`District of California, Case No. 4:17-cv-01138. Expert report and deposition.
`
`J.R. Simplot Company v. McCain Foods USA, Inc. United States District Court, District of
`Idaho, Case No. 1:16-cv-00449. Expert report and deposition.
`
`Bio-Rad Laboratories, Inc. v. 10x Genomics, Inc. United States District Court, District of
`Massachusetts, Case No. 1:19-cv-12533. Expert report and deposition.
`
`RAI Strategic Holdings, Inc. and R.J. Reynolds Vapor Company v. Altria Client Services,
`LLC; Philip Morris USA, Inc.; and Philip Morris Products S.A. United States District Court,
`Eastern District of Virginia, Case No. 1:20-cv-00393. Expert report and deposition.
`
`VLSI Technology LLC v. Intel Corporation. United States District Court, District of
`Delaware, Case No. 1:18-cv-00966. Expert report and deposition.
`
`VLSI Technology LLC v. Intel Corporation. United States District Court, Western District
`of Texas, Case Nos. 6:19-cv-00254, 6:19-cv-00255, and 6:19-cv-00256. Expert report,
`deposition, and trial.
`
`Evalve, Inc., Abbott Cardiovascular Systems, Inc., and Abbott Medical Ireland Limited v.
`Edwards Lifesciences Ireland Limited, Edwards Lifesciences Corp., and Edwards
`Lifesciences, LLC. The High Court Commercial, Record No. 2020/1219P. Expert report.
`
`CommScope, Inc. v. Rosenberger Technology (Kunshan) Co. Ltd., Rosenberger Asia Pacific
`Electronic Co., Ltd., Rosenberger Technology LLC, Rosenberger USA Corp., Rosenberger
`North America Pennsauken,
`Inc., Rosenberger Site Solutions, LLC, Rosenberger
`Hochfrequenztechnik GmbH & Co. KG, Northwest Instrument, Inc., CellMax Technologies
`AB, Janet Javier, and Robert Cameron. United States District Court, District of New
`Jersey, Case No. 2:19-cv-15962. Expert report and deposition.
`
`Dentsply Sirona, Inc. and Tulsa Dental Products LLC d/b/a Dentsply Sirona Endodontics
`v. Edge Endo, LLC and US Endodontics, LLC. United States District Court, District of New
`Mexico, Case No. 1:17-cv-01041. Expert report and deposition.
`
`CV of Ryan Sullivan, Ph.D.
`
`Page 8 of 18
`
`

`


`

`
`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 36 of 117 PageID#
`36654
`
`13.
`
`14.
`
`15.
`
`16.
`
`17.
`
`18.
`
`19.
`
`20.
`
`21.
`
`22.
`
`23.
`
`24.
`
`25.
`
`26.
`
`ClearPlay, Inc. v. DISH Network L.L.C. and EchoStar Technologies L.L.C. United States
`District Court, District of Utah, Central Division, Case No. 2:14-cv-00191. Expert report
`and deposition.
`
`Amgen Inc. and Amgen Manufacturing Limited v. Hospira, Inc. and Pfizer Inc. United States
`District Court, District of Delaware, Case No. 1:18-cv-01064. Expert report and
`deposition.
`
`Certain Botulinum Toxin Products, Processes for Manufacturing or Relating to Same and
`Certain Products Containing Same. United States International Trade Commission,
`Investigation No. 337-TA-1145. Expert report, deposition, and trial.
`
`Certain Digital Video Receivers, Broadband Gateways, and Related Hardware and
`Software Components. United States International Trade Commission, Investigation No.
`337-TA-1158. Expert report, deposition, and trial.
`
`Nike, Inc. v. Skechers U.S.A., Inc. United States District Court, Central District of
`California, Case No. 2:17-cv-08509. Expert report and deposition.
`
`Sumotext Corp. v. Zoove, Inc., Virtual Hold Technology LLC, StarSteve, LLC, and VHT
`StarStar LLC. United States District Court, Northern District of California, Case No. 5:16-
`cv-01370. Expert report, deposition, and trial.
`
`Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, and Sloan Kettering
`Institute for Cancer Research v. Kite Pharma, Inc. United States District Court, Central
`District of California, Case No. 2:17-cv-07639. Expert report, deposition, and trial.
`
`Abbott Cardiovascular Systems, Inc. and Evalve, Inc. v. Edwards Lifesciences Corp. and
`Edwards Lifesciences, LLC. United States District Court, District of Delaware, Case No.
`1:19-cv-00149. Expert report, deposition, and hearing.
`
`In the Matter of Certain LTE- and 3G- Compliant Cellular Communications Devices. United
`States International Trade Commission, Investigation No. 337-TA-1138. Expert report,
`deposition, and trial.
`
`Applied Invention, LLC v. E.I. DuPont De Nemours & Co. and Pioneer Hi-Bred International,
`Inc. American Arbitration Association, Case No. 01-18-0000-8614. Expert report.
`
`Fundamental Innovation Systems International LLC v. LG Electronics, Inc., LG Electronics
`U.S.A., Inc., LG Electronics Mobilecomm U.S.A. Inc., LG Electronics Mobile Research U.S.A.
`LLC, and LG Electronics Alabama, Inc. United States District Court, Eastern District of
`Texas, Case No. 2:16-cv-01425. Expert report and deposition.
`
`Fundamental Innovation Systems International LLC v. Huawei Device USA, Inc. and
`Huawei Device Co., Ltd. United States District Court, Eastern District of Texas, Case No.
`2:16-cv-01424. Expert report and deposition.
`
`Rovi Guides, Inc. and TiVo Solutions, Inc. v. Telus Corporation, Telus Communications, Inc.,
`and Telus Communications Company. Federal Court of Canada, Case No. T-206-18.
`Expert report and deposition.
`
`Rovi Guides, Inc. and TiVo Solutions, Inc. v. BCE, Inc., Bell Canada, Bell Aliant Regional
`Communications, Inc., Bell MTS, Inc., and NorthernTel, L.P. Federal Court of Canada, Case
`No. T-113-18. Expert report and deposition.
`
`
`CV of Ryan Sullivan, Ph.D.
`
`
`
`
`Page 9 of 18
`
`

`

`Case 1:20-cv-00393-LMB-WEF Document 1423-3 Filed 09/02/22 Page 37 of 117 PageID#
`36655
`
`27.
`
`28.
`
`29.
`
`30.
`
`31.
`
`32.
`
`33.
`
`34.
`
`35.
`
`36.
`
`37.
`
`38.
`
`39.
`
`40.
`
`Fundamental Innovation Systems International, LLC v. Samsung Electronics Co., Ltd. and
`Samsung Electronics America, Inc. United States District Court, Eastern District of Texas,
`Case No. 2:17-cv-00145. Expert report and deposition.
`
`Egenera, Inc. v. Cisco Systems, Inc. United States District Court, District of
`Massachusetts, Case No. 1:16-cv-11613. Expert report, deposition, and trial.
`
`In the Matter of Certain Microfluidic Devices. United States International Trade
`Commission, Investigation No. 337-TA-1068. Expert report, deposition, and trial.
`
`Tecsec, Incorporated v. International Business Machines Corporation, SAS Institute, Inc.,
`SAP America, Inc., SAP, AG, Cisco Systems, Inc., Oracle America, Inc. (f/k/a Sun
`Microsystems, Inc.), Sybase, Inc., Software AG, Software AG, Inc., Adobe Systems
`Incorporated, eBay, Inc., PayPal, Inc., and Oracle Corporation. United States District
`Court, Eastern District of Virginia, Case No. 1:10-cv-00115. Expert report, deposition,
`and trial.
`
`Cave Consulting Group, Inc. v. OptumInsight, Inc. United States District Court, Northern
`District of California, Case No. 3:15-cv-03424. Expert report and deposition.
`
`Bio-Rad Laboratories, Inc. and The University of Chicago v. 10x Genomics, Inc. United
`States District Court, District of Delaware, Case No. 1:15-cv-00152. Expert report
`deposition and trial.
`
`Securus Technologies, Inc. v. Global Tel*Link Corporation. United States District Court,
`Northern District of Texas, Case No. 3:16-cv-01338. Expert report.
`
`Parsons Xtreme Golf, LLC v. Taylor Made Golf Company, Inc. United States District Court,
`District of Arizona, Case No. 2:17-cv-03125. Expert report.
`
`Rovi Guides, Inc., Rovi Technologies Corp., and Veveo, Inc. v. Comcast Corporation,
`Comcast Cable Communications, LLC, Comcast Communications Management, LLC,
`Comcast of Houston, LLC, Comcast Holdings Corporation, and Comcast Shared Services,
`LLC. United States District Court, Southern District of New York, Case No. 1:16-cv-
`09278. Expert report and deposition.
`
`Credit Suisse Securities (USA) LLC v. UBS Financial Services, Inc. Financial Industry
`Regulatory Authority, Claim No. 15-03186. Expert report and trial.
`
`Ethicon Endo-Surgery, Inc. and Ethicon Endo-Surgery, LLC v. Covidien LP, Covidien Sales,
`LLC, and Covidien AG. United States District Court, District of Massachusetts, Case No.
`1:16-cv-12556. Expert report, deposition, and trial.
`
`Illumina, Inc. v. Ariosa Diagnostics, Inc. and Verinata Health, Inc. v. Ariosa Diagnostics,
`Inc. United States District Court, Northern District of California, Case Nos. 3:15-cv-
`02216, 3:14-cv-01921, and 3:12-cv-05501. Expert report, deposition, and trial.
`
`Celltrion, Inc. v. Genentech, Inc. and Biogen, Inc. United States Patent and Trademark
`Office, Patent Trial and Appeal Board, Case IPR2016-01614. Expert report.
`
`IMAX Corporation v. Three-Dimensional Media Group, Ltd. and UNIPAT.org. American
`Arbitration Association, Case No. 50-133-T-00201-06. Expert report and trial.
`
`CV of Ryan Sulli

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket